Targo 750 mg 10 tablets
Global napi pharmaceuticals
Global napi pharmaceuticals
Composition ( per 1 tablet ):
Levofloxacin hemihydrate – 750 mg . Excipients : microcrystalline cellulose , povidone , croscarmellose sodium , magnesium stearate , silicon dioxide , lactose .
Description :
Targo is a broad-spectrum antimicrobial drug from the fluoroquinolone group . It is effective against most gram-positive and gram-negative bacteria and is used to treat respiratory , urinary , skin , and soft tissue infections , as well as sepsis and complicated infectious diseases .
Properties:
Provides strong bactericidal action .
Kills a wide range of pathogenic microorganisms .
High bioavailability and rapid absorption .
Effective for severe and complicated infections .
Suitable for both short-term and long-term treatment .
Indications for Use :
Respiratory tract infections ( pneumonia , bronchitis , sinusitis ).
Urinary tract infections , including pyelonephritis .
Skin and soft tissue infections .
Sepsis and bacteremia .
Complicated intra-abdominal and urogenital infections .
Method of Application:
Adults : 1 tablet (750 mg ) once daily , regardless of meals .
Treatment duration : 5–14 days depending on infection severity .
Swallow tablets whole with sufficient water .
Dosage and treatment duration should be determined by a physician .
Storage Conditions :
Store at +5°C…+25°C, in a dry place , protected from moisture and direct sunlight .
Packaging :
Carton box containing 10 tablets .